Company Filing History:
1 out of 159 
1 out of 347 
Years Active: 2020
Title: Innovating Against Dengue: The Contributions of Erwin Cosemans
Introduction: Erwin Cosemans, a notable inventor based in Nijlen, Belgium, has made significant strides in the field of medicinal chemistry. His research has primarily centered on the development of compounds that target viral infections, particularly dengue fever. With one patent to his name, Cosemans exemplifies the spirit of innovation in addressing critical health challenges.
Latest Patents: The patent held by Erwin Cosemans pertains to "Substituted Indole Compound Derivatives as Dengue Viral Replication Inhibitors." This invention outlines a therapeutic approach involving substituted indole compounds that can prevent or treat dengue viral infections. The patent describes the utility of these compounds as medicines, specifically emphasizing their role in both preventive and therapeutic applications against dengue fever. Additionally, the invention covers pharmaceutical compositions and preparation processes for these compounds, highlighting their potential for significant impact in public health.
Career Highlights: Throughout his career, Cosemans has been associated with distinguished organizations. He has worked with Janssen Pharmaceuticals, Inc., a leading pharmaceutical company known for its innovative drug development. Cosemans has also been affiliated with Katholieke Universiteit Leuven, a prestigious university renowned for its research in various scientific disciplines. His experiences at these institutions have undoubtedly enriched his expertise in medicinal research and patenting.
Collaborations: Erwin Cosemans has collaborated with other talented researchers, including Bart Rudolf Romanie Kesteleyn and Jean-François Bonfanti. These professional relationships have contributed to the advancement of his work by fostering a collaborative environment for research and innovation in combating viral diseases.
Conclusion: Erwin Cosemans stands out as a dedicated inventor who has contributed to the fight against dengue through his innovative patent on substituted indole compounds. His collaborations with leading companies and universities reflect his commitment to advancing medical science. As research continues, Cosemans’ work will likely play a crucial role in developing effective treatments for dengue and similar viral infections.